Effect of sorafenib on sperm count and sperm motility in male Swiss albino mice

Surekha Shetty, Laxminarayana Bairy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The issue of male germ line mutagenesis and the effects on developmental defects in the next generation has become increasingly high profile over recent years. Mutagenic substance affects germinal cells in the testis. Since the cells are undergoing different phases of cell division and maturation, it is an ideal system to study the effect of chemotherapeutic agents. There are lacunae in the literature on the effect of sorafenib on gonadal function. With background, a study was planned to evaluate the effects of sorafenib on sperm count and sperm motility in male Swiss albino mice. Male Swiss albino mice were used for the study. The animals were segregated into control, positive control (PC) and three treatment groups. PC received oral imatinib (100 mg/kg body weight) and treatment groups received 25, 50, and 100 mg/kg body weight of sorafenib orally for 7 consecutive days at intervals of 24 h between two administrations. The control group remained in the home cage for an equal duration of time to match their corresponding treatment groups. The animals were sacrificed at the end of 1 st , 2 nd , 4 th , 5 th , 7 th , and 10 th weeks after the last exposure to drug, respectively. Sperm suspensions were prepared and introduced into a counting chamber. Total sperm count and motility were recorded. There was a significant decrease in sperm count and sperm motility by sorafenib which was comparable with the effect of PC imatinib. Sorafenib adversely affects sperm count and sperm motility which are reversible after discontinuation of treatment.

Original languageEnglish
Pages (from-to)165-169
Number of pages5
JournalJournal of Advanced Pharmaceutical Technology and Research
Volume6
Issue number4
DOIs
Publication statusPublished - 01-01-2015

Fingerprint

Sperm Count
Sperm Motility
Body Weight
Germ Cells
Mutagenesis
Cell Division
Spermatozoa
Testis
Suspensions
sorafenib
Control Groups
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{fe99d8a326fe4bceb94913e6661b4c6c,
title = "Effect of sorafenib on sperm count and sperm motility in male Swiss albino mice",
abstract = "The issue of male germ line mutagenesis and the effects on developmental defects in the next generation has become increasingly high profile over recent years. Mutagenic substance affects germinal cells in the testis. Since the cells are undergoing different phases of cell division and maturation, it is an ideal system to study the effect of chemotherapeutic agents. There are lacunae in the literature on the effect of sorafenib on gonadal function. With background, a study was planned to evaluate the effects of sorafenib on sperm count and sperm motility in male Swiss albino mice. Male Swiss albino mice were used for the study. The animals were segregated into control, positive control (PC) and three treatment groups. PC received oral imatinib (100 mg/kg body weight) and treatment groups received 25, 50, and 100 mg/kg body weight of sorafenib orally for 7 consecutive days at intervals of 24 h between two administrations. The control group remained in the home cage for an equal duration of time to match their corresponding treatment groups. The animals were sacrificed at the end of 1 st , 2 nd , 4 th , 5 th , 7 th , and 10 th weeks after the last exposure to drug, respectively. Sperm suspensions were prepared and introduced into a counting chamber. Total sperm count and motility were recorded. There was a significant decrease in sperm count and sperm motility by sorafenib which was comparable with the effect of PC imatinib. Sorafenib adversely affects sperm count and sperm motility which are reversible after discontinuation of treatment.",
author = "Surekha Shetty and Laxminarayana Bairy",
year = "2015",
month = "1",
day = "1",
doi = "10.4103/2231-4040.165012",
language = "English",
volume = "6",
pages = "165--169",
journal = "Journal of Advanced Pharmaceutical Technology and Research",
issn = "0110-5558",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "4",

}

Effect of sorafenib on sperm count and sperm motility in male Swiss albino mice. / Shetty, Surekha; Bairy, Laxminarayana.

In: Journal of Advanced Pharmaceutical Technology and Research, Vol. 6, No. 4, 01.01.2015, p. 165-169.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of sorafenib on sperm count and sperm motility in male Swiss albino mice

AU - Shetty, Surekha

AU - Bairy, Laxminarayana

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The issue of male germ line mutagenesis and the effects on developmental defects in the next generation has become increasingly high profile over recent years. Mutagenic substance affects germinal cells in the testis. Since the cells are undergoing different phases of cell division and maturation, it is an ideal system to study the effect of chemotherapeutic agents. There are lacunae in the literature on the effect of sorafenib on gonadal function. With background, a study was planned to evaluate the effects of sorafenib on sperm count and sperm motility in male Swiss albino mice. Male Swiss albino mice were used for the study. The animals were segregated into control, positive control (PC) and three treatment groups. PC received oral imatinib (100 mg/kg body weight) and treatment groups received 25, 50, and 100 mg/kg body weight of sorafenib orally for 7 consecutive days at intervals of 24 h between two administrations. The control group remained in the home cage for an equal duration of time to match their corresponding treatment groups. The animals were sacrificed at the end of 1 st , 2 nd , 4 th , 5 th , 7 th , and 10 th weeks after the last exposure to drug, respectively. Sperm suspensions were prepared and introduced into a counting chamber. Total sperm count and motility were recorded. There was a significant decrease in sperm count and sperm motility by sorafenib which was comparable with the effect of PC imatinib. Sorafenib adversely affects sperm count and sperm motility which are reversible after discontinuation of treatment.

AB - The issue of male germ line mutagenesis and the effects on developmental defects in the next generation has become increasingly high profile over recent years. Mutagenic substance affects germinal cells in the testis. Since the cells are undergoing different phases of cell division and maturation, it is an ideal system to study the effect of chemotherapeutic agents. There are lacunae in the literature on the effect of sorafenib on gonadal function. With background, a study was planned to evaluate the effects of sorafenib on sperm count and sperm motility in male Swiss albino mice. Male Swiss albino mice were used for the study. The animals were segregated into control, positive control (PC) and three treatment groups. PC received oral imatinib (100 mg/kg body weight) and treatment groups received 25, 50, and 100 mg/kg body weight of sorafenib orally for 7 consecutive days at intervals of 24 h between two administrations. The control group remained in the home cage for an equal duration of time to match their corresponding treatment groups. The animals were sacrificed at the end of 1 st , 2 nd , 4 th , 5 th , 7 th , and 10 th weeks after the last exposure to drug, respectively. Sperm suspensions were prepared and introduced into a counting chamber. Total sperm count and motility were recorded. There was a significant decrease in sperm count and sperm motility by sorafenib which was comparable with the effect of PC imatinib. Sorafenib adversely affects sperm count and sperm motility which are reversible after discontinuation of treatment.

UR - http://www.scopus.com/inward/record.url?scp=84944687411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944687411&partnerID=8YFLogxK

U2 - 10.4103/2231-4040.165012

DO - 10.4103/2231-4040.165012

M3 - Article

VL - 6

SP - 165

EP - 169

JO - Journal of Advanced Pharmaceutical Technology and Research

JF - Journal of Advanced Pharmaceutical Technology and Research

SN - 0110-5558

IS - 4

ER -